BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Noll ATR, Cramer T, Olde Damink SWM, Schaap FG. Cholangiocarcinoma, gone without the Wnt? World J Hepatol 2016; 8(26): 1093-1096 [PMID: 27660676 DOI: 10.4254/wjh.v8.i26.1093]
URL: https://www.wjgnet.com/1948-5182/full/v8/i26/1093.htm
Number Citing Articles
1
Shuai He, Shilei Tang. WNT/β-catenin signaling in the development of liver cancersBiomedicine & Pharmacotherapy 2020; 132: 110851 doi: 10.1016/j.biopha.2020.110851
2
Adrian P. Mansini, Estanislao Peixoto, Kristen M. Thelen, Cesar Gaspari, Sujeong Jin, Sergio A. Gradilone. The cholangiocyte primary cilium in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1245 doi: 10.1016/j.bbadis.2017.06.006
3
Rita Manco, Isabelle A. Leclercq, Laure-Alix Clerbaux. Liver Regeneration: Different Sub-Populations of Parenchymal Cells at Play Choreographed by an Injury-Specific MicroenvironmentInternational Journal of Molecular Sciences 2018; 19(12): 4115 doi: 10.3390/ijms19124115
4
Yongqin Ye, Vincent Chi Hang Lui, Paul Kwong Hang Tam. Pathogenesis of Choledochal Cyst: Insights from Genomics and TranscriptomicsGenes 2022; 13(6): 1030 doi: 10.3390/genes13061030
5
Guo-Feng Zhang, Ling Qiu, Shu-Li Yang, Jia-Cheng Wu, Tong-Jun Liu. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinomaBioscience Reports 2020; 40(3) doi: 10.1042/BSR20193353
6
Norma Pangestu, Piyasiri Chueakwon, Krajang Talabnin, Juthamas Khiaowichit, Chutima Talabnin. RNF43 overexpression attenuates the Wnt/β‑catenin signalling pathway to suppress tumour progression in cholangiocarcinomaOncology Letters 2021; 22(6) doi: 10.3892/ol.2021.13107